Characterization of an Animal Model to Study Risk Factors and New Therapies for the Cardiorenal Syndrome, a Major Health Issue in Our Aging Population
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of an Animal Model to Study Risk Factors and New Therapies for the Cardiorenal Syndrome, a Major Health Issue in Our Aging Population
Authors
Keywords
-
Journal
CardioRenal Medicine
Volume 7, Issue 3, Pages 234-244
Publisher
S. Karger AG
Online
2017-05-24
DOI
10.1159/000462984
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease
- (2016) Olga A. Agapova et al. KIDNEY INTERNATIONAL
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia
- (2015) David M. Charytan et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease
- (2015) Ellen Neven et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients
- (2015) Ajay Gupta et al. KIDNEY INTERNATIONAL
- Target Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study
- (2015) Eyal Ben-Assa et al. CardioRenal Medicine
- RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice
- (2014) Jacqueline M. Langdon et al. AMERICAN JOURNAL OF HEMATOLOGY
- The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences
- (2014) IJsbrand T. Klip et al. EUROPEAN JOURNAL OF HEART FAILURE
- An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
- (2014) Michael Dussiot et al. NATURE MEDICINE
- Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
- (2013) Josep Comín-Colet et al. EUROPEAN JOURNAL OF HEART FAILURE
- A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats
- (2013) Chia Chi Sun et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hepcidin and iron homeostasis
- (2012) Tomas Ganz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
- (2012) E. A. Jankowska et al. EUROPEAN HEART JOURNAL
- Activin receptor antagonists for cancer-related anemia and bone disease
- (2012) Scott Z Fields et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mechanisms of Anemia in CKD
- (2012) J. L. Babitt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hepcidin and the Iron-Infection Axis
- (2012) H. Drakesmith et al. SCIENCE
- Atrial natriuretic peptides in Han Wistar, Sprague-Dawley and spontaneously Hypertensive rats
- (2011) Federica Crivellente et al. JOURNAL OF APPLIED TOXICOLOGY
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
- (2009) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiorenal Syndrome
- (2008) Claudio Ronco et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started